Rekvina Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
27.68
0.54 (1.99%)
BSENSE

Mar 02

BSE+NSE Vol: 8.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 576337,
    "name": "Rekvina Labs",
    "stock_name": "Rekvina Labs",
    "full_name": "Rekvina Labs Ltd",
    "name_url": "stocks-analysis/rekvina-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.68",
    "chg": 0.54,
    "chgp": "1.99%",
    "dir": 1,
    "prev_price": "27.14",
    "mcapval": "16.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526075,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE092O01028",
    "curr_date": "Mar 02",
    "curr_time": "",
    "bse_nse_vol": "8.39 k",
    "exc_status": "Active",
    "traded_date": "Mar 02, 2026",
    "traded_date_str": "2026 03 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rekvina-labs-576337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High at Rs.27.68",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs2768-3865308",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/RekvinaLabsLtd_priceRelatedfactors_3865308.png",
        "date": "2026-03-02 13:41:00",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.27.68, marking a significant milestone in its stock performance. This new peak reflects sustained momentum, with the stock demonstrating robust gains over the past three weeks and outperforming its sector peers."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.27.14 on 27 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2714-on-27-feb-2026-3860230",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3860230.png",
        "date": "2026-02-27 11:19:08",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.27.14 today, reflecting a remarkable rally that has seen the stock more than double over the past three weeks. This milestone underscores the stock’s robust momentum amid a broader market environment where the Sensex has experienced a modest decline."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.26.61 on 26 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2661-on-26-feb-2026-3858036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3858036.png",
        "date": "2026-02-26 10:54:41",
        "description": "Rekvina Labs Ltd achieved a significant milestone on 26 Feb 2026, reaching a new 52-week high of Rs.26.61. This marks a remarkable rally for the stock, which has demonstrated strong momentum over the past three weeks, outperforming its sector and trading well above key moving averages."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.26.09 on 25 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2609-on-25-feb-2026-3855494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3855494.png",
        "date": "2026-02-25 10:54:41",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.26.09 today, reflecting a remarkable rally that has seen the stock gain 138.48% over the past 21 trading sessions. This milestone underscores the stock’s strong momentum and sustained upward trajectory in recent weeks."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.25.58 on 24 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2558-on-24-feb-2026-3853035",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3853035.png",
        "date": "2026-02-24 11:19:41",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.25.58 today, reflecting a remarkable rally that has seen the stock gain over 145% in the past 21 trading sessions. This milestone underscores the stock’s robust upward momentum, significantly outperforming its sector and broader market indices despite a subdued Sensex environment."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High at Rs.25.08",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs2508-3851395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3851395.png",
        "date": "2026-02-23 10:38:23",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.25.08 today, reflecting a remarkable rally that has seen the stock gain over 150% in the past 21 trading sessions. This milestone underscores the stock’s robust momentum and sustained upward trajectory across multiple moving averages."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High at Rs.24.59",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs2459-3848718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3848718.png",
        "date": "2026-02-20 14:40:40",
        "description": "Rekvina Labs Ltd achieved a significant milestone on 20 Feb 2026, reaching a new 52-week high of Rs.24.59. This marks a continuation of a strong upward momentum, with the stock registering gains for 21 consecutive trading sessions and delivering a remarkable 159.94% return over this period."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.24.11 on 19 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2411-on-19-feb-2026-3846947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3846947.png",
        "date": "2026-02-19 10:48:20",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.24.11 today, reflecting a remarkable rally that has seen the stock gain 167.59% over the past 21 trading sessions. This milestone underscores the strong momentum the stock has built, trading well above all key moving averages and outperforming its sector in recent sessions."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.23.64 on 18 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2364-on-18-feb-2026-3845819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3845819.png",
        "date": "2026-02-18 11:11:44",
        "description": "Rekvina Labs Ltd reached a fresh 52-week high of Rs.23.64 today, underscoring a remarkable rally that has seen the stock surge by 175.2% over the past 21 trading sessions. This milestone highlights the stock’s strong momentum amid a mixed market backdrop."
      }
    ],
    "total": 33,
    "sid": "576337",
    "stock_news_url": "https://www.marketsmojo.com/news/rekvina-labs-576337"
  },
  "announcements": [
    {
      "caption": "Financial Results For The Quarter And Nine Months Ended On 31St December 2025.",
      "datetime": "09-Feb-2026",
      "details": "Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 06th February 2026 has inter-alia adopted and approved. 1. Financial Results for the Quarter and Nine Month ended on 31st December 2025. 2. Limited Review Report by Statutory Auditor of the Company on Standalone in-audited Financial Results for the Nine Month & Quarter ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February 2026",
      "datetime": "06-Feb-2026",
      "details": "Dear Sir/Madam Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 6th February 2026 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:32 P.M. This is for your information and record Thanking you For Rekvina Laboratories Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "29-Jan-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 29th January 2026 have considered and approve appointment of Mr. Jay Chintan Patel as an Additional Non-Executive Independent Director.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Rekvina Labs Ltd has announced <strong>5:10</strong> stock split, ex-date: 30 Apr 14",
          "dt": "2014-04-30",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Financial Results For The Quarter And Nine Months Ended On 31St December 2025.

09-Feb-2026 | Source : BSE

Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 06th February 2026 has inter-alia adopted and approved. 1. Financial Results for the Quarter and Nine Month ended on 31st December 2025. 2. Limited Review Report by Statutory Auditor of the Company on Standalone in-audited Financial Results for the Nine Month & Quarter ended on 31st December 2025.

Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February 2026

06-Feb-2026 | Source : BSE

Dear Sir/Madam Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 6th February 2026 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:32 P.M. This is for your information and record Thanking you For Rekvina Laboratories Limited

Announcement under Regulation 30 (LODR)-Change in Directorate

29-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 29th January 2026 have considered and approve appointment of Mr. Jay Chintan Patel as an Additional Non-Executive Independent Director.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Rekvina Labs Ltd has announced 5:10 stock split, ex-date: 30 Apr 14

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available